Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Richtig, G; Hoeller, C; Kashofer, K; Aigelsreiter, A; Heinemann, A; Kwong, LN; Pichler, M; Richtig, E.
Beyond the BRAFV600E hotspot: biology and clinical implications of rare BRAF gene mutations in melanoma patients.
Br J Dermatol. 2017; 177(4):936-944
Doi: 10.1111/bjd.15436
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Richtig Georg
- Co-Autor*innen der Med Uni Graz
- Aigelsreiter Ariane
- Heinemann Akos
- Kashofer Karl
- Pichler Martin
- Richtig Erika
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BRAF gene mutations can be found in approximately 50% of melanomas, but the most common BRAF mutation leads to substitution at residue 600 of the protein, from valine to glutamic acid. BRAFV600E occurs in up to 95% of all melanoma cases and can be successfully blocked by using a combination of BRAF- and MEK inhibitors. The wider availability of next-generation sequencing is revealing more non-V600 BRAF mutations, and the clinical implications of these mutations are widely unknown. In this review, we will discuss the biology of the MAPK pathway and the different types of BRAF mutations as well as their effect on MEK activation. Current literature will be reviewed including in vitro data, case reports and case series. © 2017 British Association of Dermatologists.
- Find related publications in this database (using NLM MeSH Indexing)
- Humans -
- MAP Kinase Kinase Kinases - genetics
- MAP Kinase Signaling System - genetics
- MAP Kinase Signaling System - physiology
- Melanoma - genetics
- Mutation - genetics
- Neoplasm Proteins - genetics
- Oncogene Proteins, Fusion - genetics
- Proto-Oncogene Proteins B-raf - genetics
- Skin Neoplasms - genetics
- ras Proteins - genetics